REGULATION ON GALLBLADDER CANCER CELL CYCLE REVERT ITS CHEMORESISTANCE ON DOXORUBICIN IN VITRO & IN VIVO

全志伟,李济宇,张强,刘建文
DOI: https://doi.org/10.3969/j.issn.1006-4761.2004.04.031
2004-01-01
Abstract:Objective To investigate chemosensitivity of Doxorubicin(DOX) on human gallbladder cancer cell line GVC SD and its xenograft,after modulation of the gallbladder cancer cell cycle by Somatostatin.Methods Chemosensitivity of DOX on GBC SD in vitro was investigated using MTT assay after somatostatin pre treated.Then,xenograft of GBC SD cell line was found to investigate the effect of somatostain or DOX use only and combined use(Co use)on gallbladder cancer cell in vivo.Result Cancer cell growth arrest in S phrase reducing by somatostatin was detected,which resulted in reverting its chemotherapy resistance to DOX (P0.05).Inhibition of GBC SD xenograft growth was not found by somatostatin or DOX use only.While Co use caused significant inhibition of GBC SD xenograft growth(P0.05).And this inhibition was somatostatin concentration dependent.Conclusion Modulation on gallbladder cancer cell cycle could increase its chemosensitivity in vitro and in vivo.
What problem does this paper attempt to address?